| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 1.09e-05 | 6 | 165 | 3 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 1.09e-05 | 6 | 165 | 3 | GO:0055131 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | LONP2 SMC1A WRN CCT4 ATP8A1 ATP2C2 DDX60L MTREX HSPA1A HSPA1B DNAH8 HSPA5 HSPA8 XRCC6 | 1.86e-05 | 441 | 165 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 1.89e-05 | 40 | 165 | 5 | GO:0140662 | |
| GeneOntologyMolecularFunction | fatty acid binding | 2.27e-05 | 69 | 165 | 6 | GO:0005504 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 3.02e-05 | 107 | 165 | 7 | GO:0033293 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 4.49e-05 | 9 | 165 | 3 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 4.49e-05 | 9 | 165 | 3 | GO:0099626 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 7.88e-05 | 28 | 165 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.72e-04 | 239 | 165 | 9 | GO:0031406 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | LONP2 SMC1A WRN CCT4 ATP8A1 ATP2C2 DYNC1LI1 DDX60L MTREX HSPA1A HSPA1B DNAH8 HSPA5 HSPA8 XRCC6 | 1.81e-04 | 614 | 165 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.89e-04 | 14 | 165 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.93e-04 | 35 | 165 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | denatured protein binding | 2.03e-04 | 3 | 165 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 2.34e-04 | 15 | 165 | 3 | GO:0140776 | |
| GeneOntologyMolecularFunction | organic acid binding | 2.71e-04 | 254 | 165 | 9 | GO:0043177 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 3.46e-04 | 73 | 165 | 5 | GO:0044183 | |
| GeneOntologyMolecularFunction | misfolded protein binding | 4.13e-04 | 18 | 165 | 3 | GO:0051787 | |
| GeneOntologyMolecularFunction | retinoid binding | 6.59e-04 | 48 | 165 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 6.68e-04 | 5 | 165 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 7.13e-04 | 49 | 165 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | LONP2 SMC1A WRN CCT4 ATP8A1 ATP2C2 DDX60L MTREX HSPA1A HSPA1B DNAH8 HSPA5 HSPA8 GPN3 XRCC6 | 1.97e-03 | 775 | 165 | 15 | GO:0017111 |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 1.82e-08 | 5 | 162 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 5.43e-08 | 6 | 162 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 5.43e-08 | 6 | 162 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 5.43e-08 | 6 | 162 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 7.42e-07 | 10 | 162 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 7.42e-07 | 10 | 162 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CACNA1E MAP7D3 SMC1A PRSS55 CHORDC1 AP3B1 FSIP2 ROPN1L SETD2 ALMS1 MEGF8 SYNE2 AP3B2 NAT10 CHMP3 DYNC1LI1 DLG1 CFAP74 SPAG17 HSPA1A HSPA1B DNAH8 HYDIN HSPA8 MYBL2 | 7.98e-07 | 1058 | 162 | 25 | GO:0007017 |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 2.48e-06 | 13 | 162 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | chaperone-mediated protein folding | 3.18e-06 | 80 | 162 | 7 | GO:0061077 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 4.70e-06 | 5 | 162 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MAP7D3 SMC1A CHORDC1 FSIP2 SETD2 ALMS1 SYNE2 NAT10 CHMP3 DYNC1LI1 DLG1 CFAP74 SPAG17 HSPA1A HSPA1B DNAH8 HYDIN MYBL2 | 1.51e-05 | 720 | 162 | 18 | GO:0000226 |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.98e-05 | 21 | 162 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 1.98e-05 | 21 | 162 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | regulation of vesicle size | 2.40e-05 | 22 | 162 | 4 | GO:0097494 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 4.79e-05 | 26 | 162 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 4.79e-05 | 26 | 162 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 5.42e-05 | 52 | 162 | 5 | GO:0008210 | |
| GeneOntologyBiologicalProcess | protein refolding | 8.57e-05 | 30 | 162 | 4 | GO:0042026 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 9.93e-05 | 12 | 162 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | regulation of centrosome cycle | 1.37e-04 | 63 | 162 | 5 | GO:0046605 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.42e-04 | 34 | 162 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | regulation of cellular component size | RIN3 CARMIL1 PCLO NEB SHROOM2 PICALM MEGF8 CHMP3 DLG1 ARHGAP18 IQGAP3 KDM1A | 1.43e-04 | 426 | 162 | 12 | GO:0032535 |
| GeneOntologyBiologicalProcess | microtubule-based movement | CACNA1E PRSS55 AP3B1 FSIP2 ROPN1L MEGF8 SYNE2 AP3B2 DYNC1LI1 SPAG17 DNAH8 HYDIN HSPA8 | 1.45e-04 | 493 | 162 | 13 | GO:0007018 |
| GeneOntologyBiologicalProcess | chaperone cofactor-dependent protein refolding | 1.59e-04 | 35 | 162 | 4 | GO:0051085 | |
| GeneOntologyBiologicalProcess | intracellular transport | MON2 NUP50 RGPD2 PSAP LONP2 AHCTF1 AP3B1 PICALM SDAD1 SETD2 ALMS1 EGR2 SYNE2 AP3B2 CHMP3 DYNC1LI1 UMOD NUP188 NUP93 AP4B1 SPAG17 HSPA1A HSPA1B HSPA5 HSPA8 | 2.68e-04 | 1496 | 162 | 25 | GO:0046907 |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 2.69e-04 | 40 | 162 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | 'de novo' post-translational protein folding | 2.96e-04 | 41 | 162 | 4 | GO:0051084 | |
| GeneOntologyBiologicalProcess | telomere maintenance | 3.71e-04 | 168 | 162 | 7 | GO:0000723 | |
| GeneOntologyBiologicalProcess | 'de novo' protein folding | 4.63e-04 | 46 | 162 | 4 | GO:0006458 | |
| GeneOntologyCellularComponent | inclusion body | 7.95e-05 | 90 | 165 | 6 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear pore | 1.51e-04 | 101 | 165 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | aggresome | 2.74e-04 | 40 | 165 | 4 | GO:0016235 | |
| Domain | AP_beta | 6.21e-06 | 5 | 161 | 3 | IPR026739 | |
| Domain | HSP70 | 8.93e-06 | 16 | 161 | 4 | PF00012 | |
| Domain | HSP70_2 | 1.16e-05 | 17 | 161 | 4 | PS00329 | |
| Domain | HSP70_1 | 1.16e-05 | 17 | 161 | 4 | PS00297 | |
| Domain | HSP70_3 | 1.16e-05 | 17 | 161 | 4 | PS01036 | |
| Domain | Hsp_70_fam | 1.48e-05 | 18 | 161 | 4 | IPR013126 | |
| Domain | Ca_chan_IQ | 2.15e-05 | 7 | 161 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 2.15e-05 | 7 | 161 | 3 | PF08763 | |
| Domain | VDCC_a1su_IQ | 2.15e-05 | 7 | 161 | 3 | IPR014873 | |
| Domain | GPHH | 2.15e-05 | 7 | 161 | 3 | PF16905 | |
| Domain | GPHH_dom | 2.15e-05 | 7 | 161 | 3 | IPR031649 | |
| Domain | UDPGT | 2.84e-05 | 21 | 161 | 4 | PF00201 | |
| Domain | UDPGT | 2.84e-05 | 21 | 161 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 2.84e-05 | 21 | 161 | 4 | IPR002213 | |
| Domain | VDCCAlpha1 | 7.22e-05 | 10 | 161 | 3 | IPR002077 | |
| Domain | AP3_beta | 7.39e-05 | 2 | 161 | 2 | IPR026740 | |
| Domain | AP3B_C | 7.39e-05 | 2 | 161 | 2 | IPR029390 | |
| Domain | AP3B1_C | 7.39e-05 | 2 | 161 | 2 | PF14796 | |
| Domain | AP3B1_C | 7.39e-05 | 2 | 161 | 2 | SM01355 | |
| Domain | - | 1.31e-04 | 12 | 161 | 3 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 1.31e-04 | 12 | 161 | 3 | IPR029047 | |
| Domain | - | 1.69e-04 | 13 | 161 | 3 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 1.69e-04 | 13 | 161 | 3 | IPR018181 | |
| Domain | HSP70_C | 1.69e-04 | 13 | 161 | 3 | IPR029048 | |
| Domain | Clathrin/coatomer_adapt-like_N | 2.65e-04 | 15 | 161 | 3 | IPR002553 | |
| Domain | Adaptin_N | 2.65e-04 | 15 | 161 | 3 | PF01602 | |
| Domain | MAGUK_N_PEST | 4.38e-04 | 4 | 161 | 2 | PF10608 | |
| Domain | PDZ_assoc | 4.38e-04 | 4 | 161 | 2 | PF10600 | |
| Domain | DLG1_PEST_dom | 4.38e-04 | 4 | 161 | 2 | IPR019590 | |
| Domain | PDZ_assoc | 4.38e-04 | 4 | 161 | 2 | IPR019583 | |
| Domain | MAGUK_N_PEST | 4.38e-04 | 4 | 161 | 2 | SM01277 | |
| Domain | DLG1 | 4.38e-04 | 4 | 161 | 2 | IPR016313 | |
| Domain | B2-adapt-app_C | 4.38e-04 | 4 | 161 | 2 | SM01020 | |
| Domain | B-adaptin_app_sub_C | 4.38e-04 | 4 | 161 | 2 | IPR015151 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.10e-07 | 73 | 122 | 8 | MM14948 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.27e-06 | 92 | 122 | 8 | MM14951 | |
| Pathway | WP_GLUCURONIDATION | 2.07e-06 | 25 | 122 | 5 | MM15820 | |
| Pathway | WP_GLUCURONIDATION | 2.54e-06 | 26 | 122 | 5 | M39404 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 6.79e-06 | 82 | 122 | 7 | M27250 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.68e-05 | 101 | 122 | 7 | M27253 | |
| Pathway | WP_ESTROGEN_METABOLISM | 3.46e-05 | 22 | 122 | 4 | MM15888 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.96e-05 | 24 | 122 | 4 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 5.87e-05 | 25 | 122 | 4 | M17787 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 5.87e-05 | 25 | 122 | 4 | M605 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 7.64e-05 | 51 | 122 | 5 | M17726 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 9.31e-05 | 28 | 122 | 4 | M19580 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 9.92e-05 | 11 | 122 | 3 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 9.92e-05 | 11 | 122 | 3 | M26913 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 9.92e-05 | 11 | 122 | 3 | M47958 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.10e-04 | 55 | 122 | 5 | M14933 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.70e-04 | 13 | 122 | 3 | MM14952 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 1.80e-04 | 33 | 122 | 4 | M27016 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | RGPD2 SMC1A AHCTF1 HDAC8 PPP2R1B CHMP3 DYNC1LI1 NUP188 NUP93 | 1.97e-04 | 234 | 122 | 9 | MM14898 |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 2.15e-04 | 14 | 122 | 3 | M39328 | |
| Pathway | KEGG_RETINOL_METABOLISM | 2.27e-04 | 64 | 122 | 5 | M9488 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 3.37e-04 | 151 | 122 | 7 | M550 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 3.45e-04 | 70 | 122 | 5 | M16794 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 3.47e-04 | 39 | 122 | 4 | MM15695 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 3.84e-04 | 40 | 122 | 4 | MM14945 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 3.94e-04 | 72 | 122 | 5 | M9257 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 4.22e-04 | 41 | 122 | 4 | M7399 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 4.22e-04 | 41 | 122 | 4 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 4.64e-04 | 42 | 122 | 4 | MM15039 | |
| Pathway | BIOCARTA_PDZS_PATHWAY | 4.69e-04 | 18 | 122 | 3 | M22001 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 5.08e-04 | 43 | 122 | 4 | MM14609 | |
| Pathway | REACTOME_M_PHASE | NUP50 RGPD2 SMC1A AHCTF1 HDAC8 PPP2R1B ALMS1 CHMP3 DYNC1LI1 NUP188 NUP93 | 5.32e-04 | 387 | 122 | 11 | MM15364 |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 5.37e-04 | 77 | 122 | 5 | M27226 | |
| Pathway | REACTOME_ASPIRIN_ADME | 6.05e-04 | 45 | 122 | 4 | MM15694 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 7.14e-04 | 47 | 122 | 4 | MM14939 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 8.00e-04 | 84 | 122 | 5 | MM14929 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 8.37e-04 | 49 | 122 | 4 | MM14837 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 8.88e-04 | 129 | 122 | 6 | MM14894 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 8.90e-04 | 86 | 122 | 5 | MM15413 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 9.04e-04 | 50 | 122 | 4 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 9.75e-04 | 51 | 122 | 4 | MM15151 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 9.87e-04 | 23 | 122 | 3 | M47666 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 9.87e-04 | 23 | 122 | 3 | MM14953 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 1.03e-03 | 236 | 122 | 8 | M27185 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.05e-03 | 52 | 122 | 4 | M14171 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.05e-03 | 52 | 122 | 4 | MM14949 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 1.12e-03 | 24 | 122 | 3 | M46445 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 1.12e-03 | 24 | 122 | 3 | MM15658 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.27e-03 | 25 | 122 | 3 | M47948 | |
| Pathway | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | 1.30e-03 | 55 | 122 | 4 | MM15098 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.30e-03 | 55 | 122 | 4 | MM14917 | |
| Pathway | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | 1.39e-03 | 56 | 122 | 4 | M1877 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.48e-03 | 57 | 122 | 4 | M27251 | |
| Pathway | REACTOME_NRCAM_INTERACTIONS | 1.52e-03 | 7 | 122 | 2 | M27378 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.58e-03 | 58 | 122 | 4 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.58e-03 | 58 | 122 | 4 | MM14736 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 1.59e-03 | 27 | 122 | 3 | M29807 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.77e-03 | 28 | 122 | 3 | M27254 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.87e-03 | 202 | 122 | 7 | MM15362 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 2.13e-03 | 153 | 122 | 6 | MM15844 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 2.16e-03 | 30 | 122 | 3 | M18193 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 2.39e-03 | 211 | 122 | 7 | MM14502 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 2.41e-03 | 65 | 122 | 4 | MM15147 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 2.54e-03 | 66 | 122 | 4 | MM17074 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 2.61e-03 | 32 | 122 | 3 | M29579 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 2.61e-03 | 32 | 122 | 3 | MM15143 | |
| Pubmed | Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. | 2.55e-09 | 5 | 167 | 4 | 16906134 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SRRM1 KDM3A ZHX3 SMC1A AHCTF1 WRN PRDM2 FSIP2 SBNO1 FANCI NAT10 ELF1 XRCC6 KDM1A DNMT1 MYBL2 BRWD1 | 6.99e-09 | 608 | 167 | 17 | 36089195 |
| Pubmed | Genetic aspects of the hsp70 multigene family in vertebrates. | 7.63e-09 | 6 | 167 | 4 | 7988674 | |
| Pubmed | 7.63e-09 | 6 | 167 | 4 | 32527940 | ||
| Pubmed | 7.63e-09 | 6 | 167 | 4 | 20297805 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 1.12e-08 | 57 | 167 | 7 | 21886157 | |
| Pubmed | NUP50 KDM3A ZHX3 TDP2 SBNO1 FANCI NAT10 ELF1 MTREX XRCC6 KDM1A DNMT1 MYBL2 | 1.16e-08 | 339 | 167 | 13 | 30415952 | |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 1.77e-08 | 7 | 167 | 4 | 8467709 | |
| Pubmed | 1.77e-08 | 7 | 167 | 4 | 8464825 | ||
| Pubmed | 1.77e-08 | 7 | 167 | 4 | 27514509 | ||
| Pubmed | NUP50 KDM3A ZHX3 SMC1A NAB1 CCT4 BCL9 TDP2 PRDM2 ARL6IP4 PRAM1 FANCI DYNC1LI1 ELF1 NUP93 MTREX HSPA1B HSPA8 XRCC6 KDM1A DNMT1 MYBL2 | 1.83e-08 | 1103 | 167 | 22 | 34189442 | |
| Pubmed | 3.54e-08 | 8 | 167 | 4 | 20610558 | ||
| Pubmed | 3.54e-08 | 8 | 167 | 4 | 18052087 | ||
| Pubmed | 3.54e-08 | 8 | 167 | 4 | 17179145 | ||
| Pubmed | 6.34e-08 | 9 | 167 | 4 | 22511988 | ||
| Pubmed | 6.34e-08 | 9 | 167 | 4 | 21763498 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NUP50 POLR1A SMC1A PCLO APLP2 CCT4 CHORDC1 AP3B1 SDAD1 PRDM2 SBNO1 FANCI NAT10 DYNC1LI1 NUP188 NUP93 MTREX HSPA1A HSPA5 IQGAP3 HSPA8 XRCC6 KDM1A DNMT1 | 9.43e-08 | 1425 | 167 | 24 | 30948266 |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 9.49e-08 | 24 | 167 | 5 | 24625756 | |
| Pubmed | 1.05e-07 | 10 | 167 | 4 | 23642732 | ||
| Pubmed | Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. | 1.05e-07 | 10 | 167 | 4 | 11932435 | |
| Pubmed | 1.05e-07 | 10 | 167 | 4 | 12832005 | ||
| Pubmed | 1.05e-07 | 10 | 167 | 4 | 11465080 | ||
| Pubmed | 1.05e-07 | 10 | 167 | 4 | 7906708 | ||
| Pubmed | 1.05e-07 | 10 | 167 | 4 | 23921388 | ||
| Pubmed | 1.05e-07 | 10 | 167 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 1.05e-07 | 10 | 167 | 4 | 22558097 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 23352621 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 38996073 | ||
| Pubmed | Stored of Hsp72/Hsp73 in germinal vesicle-stage mouse oocytes. | 1.09e-07 | 3 | 167 | 3 | 15129916 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 12847094 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 29519853 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 28025138 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 1.09e-07 | 3 | 167 | 3 | 24523520 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | MAP7D3 SMC1A AHCTF1 PPHLN1 CPS1 ZFPM2 NAT10 MTREX HSPA1A HSPA5 HSPA8 XRCC6 KDM1A | 1.10e-07 | 411 | 167 | 13 | 35182466 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SRRM1 SMC1A CCT4 AP3B1 PICALM PPP2R1B FANCI NAT10 DYNC1LI1 NUP93 MTREX HSPA5 HSPA8 XRCC6 KDM1A | 1.60e-07 | 582 | 167 | 15 | 20467437 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SRRM1 KDM3A ZHX3 SMC1A CARMIL1 BCL9 PRDM2 SETD2 MAP4K1 DYNC1LI1 DLG1 ELF1 PLCB3 HSPA8 XRCC6 DNMT1 MYBL2 | 2.24e-07 | 774 | 167 | 17 | 15302935 |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 2.46e-07 | 12 | 167 | 4 | 20308471 | |
| Pubmed | 2.46e-07 | 12 | 167 | 4 | 19419973 | ||
| Pubmed | HIV-1 viral protein R (Vpr) and its interactions with host cell. | 2.46e-07 | 12 | 167 | 4 | 19275587 | |
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 2.46e-07 | 12 | 167 | 4 | 11434514 | |
| Pubmed | SMC1A AHCTF1 NAT10 DYNC1LI1 NUP93 HSPA1A HSPA1B HSPA5 HSPA8 KDM1A | 2.48e-07 | 237 | 167 | 10 | 29564676 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SRRM1 NUP50 MAP7D3 SMC1A AHCTF1 WRN PPHLN1 PRDM2 ARL6IP4 SETD2 MACO1 NAT10 NUP188 NUP93 MTREX HSPA1B HSPA5 HSPA8 XRCC6 KDM1A DNMT1 MYBL2 | 2.91e-07 | 1294 | 167 | 22 | 30804502 |
| Pubmed | 3.34e-07 | 187 | 167 | 9 | 26460568 | ||
| Pubmed | 3.54e-07 | 13 | 167 | 4 | 30792309 | ||
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 3.54e-07 | 13 | 167 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 3.54e-07 | 13 | 167 | 4 | 25246029 | |
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 4.33e-07 | 4 | 167 | 3 | 37141091 | |
| Pubmed | Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia. | 4.33e-07 | 4 | 167 | 3 | 18299791 | |
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 4.33e-07 | 4 | 167 | 3 | 32616470 | |
| Pubmed | Delayed temporal increase of hepatic Hsp70 in ApoE knockout mice after prenatal arsenic exposure. | 4.33e-07 | 4 | 167 | 3 | 22956628 | |
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 18379898 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 17558305 | ||
| Pubmed | 4.94e-07 | 14 | 167 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 4.94e-07 | 14 | 167 | 4 | 10836148 | |
| Pubmed | 4.94e-07 | 14 | 167 | 4 | 27593939 | ||
| Pubmed | 4.94e-07 | 14 | 167 | 4 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 4.94e-07 | 14 | 167 | 4 | 14672974 | |
| Pubmed | ZBTB18 inhibits SREBP-dependent lipid synthesis by halting CTBPs and LSD1 activity in glioblastoma. | 5.12e-07 | 33 | 167 | 5 | 36414381 | |
| Pubmed | SMC1A CCT4 AP3B1 PICALM FANCI NAT10 DYNC1LI1 NUP188 NUP93 MTREX HSPA1B HSPA5 HSPA8 XRCC6 KDM1A | 5.13e-07 | 638 | 167 | 15 | 33239621 | |
| Pubmed | 6.72e-07 | 15 | 167 | 4 | 10964507 | ||
| Pubmed | 7.79e-07 | 152 | 167 | 8 | 34299191 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SRRM1 NUP50 ZHX3 MAP7D3 SMC1A AHCTF1 PPHLN1 PICALM PRAM1 SETD2 FANCI NAT10 HSPA1A HSPA5 HSPA8 XRCC6 DNMT1 MYBL2 | 8.81e-07 | 954 | 167 | 18 | 36373674 |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 8.92e-07 | 16 | 167 | 4 | 19414484 | |
| Pubmed | Clathrin facilitates the morphogenesis of retrovirus particles. | 8.92e-07 | 16 | 167 | 4 | 21738476 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 1.06e-06 | 38 | 167 | 5 | 12791264 | |
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 8825650 | ||
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 11296258 | ||
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 20565459 | ||
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 15057901 | ||
| Pubmed | A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. | 1.08e-06 | 5 | 167 | 3 | 11584023 | |
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 17182002 | ||
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 15451373 | ||
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 1.16e-06 | 17 | 167 | 4 | 20639394 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MON2 SRRM1 NUP50 SMC1A APLP2 CCT4 NHLRC2 AP3B1 PICALM TDP2 PPP2R1B FANCI MACO1 DLG1 NUP188 NUP93 HSPA5 KDM1A | 1.18e-06 | 974 | 167 | 18 | 28675297 |
| Pubmed | 1.49e-06 | 18 | 167 | 4 | 20056724 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 1.88e-06 | 19 | 167 | 4 | 23281178 | |
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 2.15e-06 | 6 | 167 | 3 | 35324301 | |
| Pubmed | Phosphorylation and binding partner analysis of the TSC1-TSC2 complex. | 2.15e-06 | 6 | 167 | 3 | 15963462 | |
| Pubmed | 2.15e-06 | 6 | 167 | 3 | 9305631 | ||
| Pubmed | RING finger protein RNF207, a novel regulator of cardiac excitation. | 2.15e-06 | 6 | 167 | 3 | 25281747 | |
| Pubmed | Heat shock factor 2 is activated during mouse heart development. | 2.15e-06 | 6 | 167 | 3 | 11032181 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 2.15e-06 | 6 | 167 | 3 | 12827191 | |
| Pubmed | 2.15e-06 | 6 | 167 | 3 | 9238069 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.31e-06 | 123 | 167 | 7 | 26912792 | |
| Pubmed | Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. | 3.75e-06 | 7 | 167 | 3 | 10205060 | |
| Pubmed | Rebuilding essential active zone functions within a synapse. | 3.75e-06 | 7 | 167 | 3 | 35176221 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | SRRM1 RGPD2 SMC1A CCT4 AP3B1 ARL6IP4 NAT10 DYNC1LI1 NUP93 HSPA1A HSPA1B HSPA8 KDM1A DNMT1 | 4.47e-06 | 665 | 167 | 14 | 30457570 |
| Pubmed | 4.72e-06 | 51 | 167 | 5 | 36896912 | ||
| Pubmed | 5.06e-06 | 24 | 167 | 4 | 10617616 | ||
| Pubmed | COL6A3 PSAP SMC1A PPHLN1 CHORDC1 NEB ALMS1 SYNE2 CIPC HSPA1B HSPA8 XRCC6 | 5.64e-06 | 497 | 167 | 12 | 23414517 | |
| Pubmed | Function and regulation of heat shock factor 2 during mouse embryogenesis. | 5.98e-06 | 8 | 167 | 3 | 9122205 | |
| Pubmed | 6.00e-06 | 25 | 167 | 4 | 15456888 | ||
| Pubmed | CACNA1E SRRM1 RGPD2 PCLO ANKRD30B CCT4 NEB SBNO1 FAM186A SYNE2 ANKRD30A DLG1 DLG3 CFAP74 MCF2L SPAG17 DNAH8 TOP3B HSPA5 HSPA8 XRCC6 | 6.28e-06 | 1442 | 167 | 21 | 35575683 | |
| Pubmed | 6.87e-06 | 145 | 167 | 7 | 23349634 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 7.10e-06 | 271 | 167 | 9 | 32433965 | |
| Pubmed | 8.46e-06 | 277 | 167 | 9 | 30745168 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 8.91e-06 | 211 | 167 | 8 | 24097068 | |
| Pubmed | 8.94e-06 | 9 | 167 | 3 | 16382099 | ||
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 8.94e-06 | 9 | 167 | 3 | 20732626 | |
| Pubmed | 8.94e-06 | 9 | 167 | 3 | 8486356 | ||
| Interaction | NUP43 interactions | SRRM1 NUP50 KDM3A SMC1A AHCTF1 WRN PPHLN1 CCDC168 SDAD1 PRDM2 ARL6IP4 FSIP2 SETD2 ATP8A1 FANCI SYNE2 ELF1 NUP93 MYBL2 | 6.36e-07 | 625 | 161 | 19 | int:NUP43 |
| Interaction | SLX4 interactions | NUP50 SMC1A NAB1 WRN PPHLN1 CCT4 REV3L AP3B1 TDP2 SBNO1 FANCI UMOD NUP188 HSPA1A HSPA5 IQGAP3 HSPA8 MYBL2 | 7.82e-07 | 572 | 161 | 18 | int:SLX4 |
| Interaction | CFAP52 interactions | 2.65e-06 | 13 | 161 | 4 | int:CFAP52 | |
| Interaction | MRTFB interactions | 6.14e-06 | 57 | 161 | 6 | int:MRTFB | |
| Interaction | UGT1A7 interactions | 6.14e-06 | 57 | 161 | 6 | int:UGT1A7 | |
| Interaction | FAM83F interactions | 9.44e-06 | 36 | 161 | 5 | int:FAM83F | |
| Interaction | DVL2 interactions | ANKRD31 REV3L NEB TDP2 ARL6IP4 FANCI DLG3 NUP188 HSPA1A HSPA1B TOP3B HSPA5 IQGAP3 HSPA8 XRCC6 KDM1A | 1.05e-05 | 557 | 161 | 16 | int:DVL2 |
| Interaction | FLT1 interactions | 1.41e-05 | 179 | 161 | 9 | int:FLT1 | |
| Interaction | STIP1 interactions | SMC1A CCT4 NHLRC2 NEB AP3B1 PICALM ADGB NPRL2 FANCI MAP4K1 NAT10 TAGLN3 DYNC1LI1 NUP188 NUP93 MTREX HSPA1A HSPA1B HSPA5 HSPA8 XRCC6 KDM1A | 1.72e-05 | 1006 | 161 | 22 | int:STIP1 |
| Interaction | CEBPA interactions | NUP50 KDM3A ZHX3 SMC1A NAB1 CCT4 BCL9 TDP2 PRDM2 FABP4 ARL6IP4 PRAM1 FANCI NAT10 DYNC1LI1 ELF1 NUP93 MTREX HSPA1B HSPA5 HSPA8 XRCC6 KDM1A DNMT1 MYBL2 | 1.85e-05 | 1245 | 161 | 25 | int:CEBPA |
| Interaction | KCNA3 interactions | CACNA1B SRRM1 AFF2 MAP7D3 SMC1A CARMIL1 AHCTF1 CCT4 AP3B1 SDAD1 PRDM2 FABP4 FANCI AP3B2 DLG1 HSPA1B HSPA5 IQGAP3 HSPA8 XRCC6 | 2.16e-05 | 871 | 161 | 20 | int:KCNA3 |
| Interaction | SCN5A interactions | 3.58e-05 | 47 | 161 | 5 | int:SCN5A | |
| Interaction | HTR1E interactions | 4.06e-05 | 9 | 161 | 3 | int:HTR1E | |
| Interaction | AXL interactions | SMC1A AHCTF1 EFNB1 FANCI NAT10 DYNC1LI1 DLG1 NUP188 NUP93 HSPA1A HSPA1B HSPA8 | 4.29e-05 | 369 | 161 | 12 | int:AXL |
| Interaction | H2BC4 interactions | AHCTF1 NEB ARL6IP4 FSIP2 SBNO1 FANCI DLG3 MTREX SPAG17 XRCC6 | 4.58e-05 | 259 | 161 | 10 | int:H2BC4 |
| Interaction | CCDC142 interactions | 5.76e-05 | 10 | 161 | 3 | int:CCDC142 | |
| Interaction | ZBTB18 interactions | 6.44e-05 | 53 | 161 | 5 | int:ZBTB18 | |
| Interaction | CDC34 interactions | SMC1A AHCTF1 NAT10 DYNC1LI1 NUP93 HSPA1A HSPA1B HSPA5 HSPA8 KDM1A MYBL2 | 6.84e-05 | 328 | 161 | 11 | int:CDC34 |
| Interaction | INO80 interactions | 7.01e-05 | 87 | 161 | 6 | int:INO80 | |
| Interaction | JPT2 interactions | 7.71e-05 | 55 | 161 | 5 | int:JPT2 | |
| Interaction | PXN interactions | MON2 MAP7D3 PICALM ALMS1 DYNC1LI1 HSPA1A TOP3B HSPA5 IQGAP3 HSPA8 KDM1A | 8.04e-05 | 334 | 161 | 11 | int:PXN |
| Interaction | CIT interactions | SRRM1 NUP50 POLR1A UGT1A7 SMC1A AHCTF1 PCLO CCT4 CPS1 PICALM ALMS1 FANCI SYNE2 NAT10 ELF1 DDX60L NUP188 NUP93 MTREX SPAG17 TOP3B HSPA5 HSPA8 XRCC6 KDM1A CCSER1 | 8.38e-05 | 1450 | 161 | 26 | int:CIT |
| Interaction | EPS15L1 interactions | 1.23e-04 | 138 | 161 | 7 | int:EPS15L1 | |
| Interaction | AP5Z1 interactions | 1.34e-04 | 33 | 161 | 4 | int:AP5Z1 | |
| Interaction | UGT1A9 interactions | 1.35e-04 | 13 | 161 | 3 | int:UGT1A9 | |
| Interaction | DYSF interactions | 1.37e-04 | 62 | 161 | 5 | int:DYSF | |
| Interaction | MECOM interactions | SMC1A AHCTF1 NEB EGR2 NAT10 NUP93 MTREX IQGAP3 XRCC6 KDM1A CA3 | 1.48e-04 | 358 | 161 | 11 | int:MECOM |
| Interaction | PRDM16 interactions | 1.77e-04 | 195 | 161 | 8 | int:PRDM16 | |
| Interaction | NUP214 interactions | 1.77e-04 | 195 | 161 | 8 | int:NUP214 | |
| Interaction | H3C3 interactions | SRRM1 KDM3A ZHX3 SMC1A AHCTF1 PRDM2 FSIP2 SBNO1 FANCI NAT10 XRCC6 KDM1A DNMT1 | 1.78e-04 | 495 | 161 | 13 | int:H3C3 |
| Interaction | UGT1A8 interactions | 1.89e-04 | 3 | 161 | 2 | int:UGT1A8 | |
| Interaction | METTL21A interactions | 1.89e-04 | 36 | 161 | 4 | int:METTL21A | |
| Cytoband | 2q37 | 9.44e-08 | 31 | 167 | 5 | 2q37 | |
| Cytoband | Xp22.3 | 7.94e-05 | 23 | 167 | 3 | Xp22.3 | |
| Cytoband | 2p11.2 | 9.05e-05 | 64 | 167 | 4 | 2p11.2 | |
| Cytoband | 1q44 | 7.22e-04 | 110 | 167 | 4 | 1q44 | |
| GeneFamily | Heat shock 70kDa proteins | 2.41e-06 | 17 | 105 | 4 | 583 | |
| GeneFamily | UDP glucuronosyltransferases | 3.41e-05 | 32 | 105 | 4 | 363 | |
| GeneFamily | Nucleoporins | 3.41e-05 | 32 | 105 | 4 | 1051 | |
| GeneFamily | Calcium voltage-gated channel subunits | 4.49e-04 | 26 | 105 | 3 | 253 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CACNA1A CACNA1E AFF2 COL6A6 PCLO REV3L NEB SHROOM2 ZFPM2 PRDM2 FSIP2 ATP8A1 MACO1 AP3B2 DLG3 MCF2L SPAG17 HYDIN CCDC144A BRWD1 CCSER1 | 5.47e-06 | 1106 | 163 | 21 | M39071 |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.96e-07 | 179 | 167 | 8 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | facs-Heart-RV|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-07 | 185 | 167 | 8 | 7cf2b0db059605032bfae60cf1b93c4c62608f0c | |
| ToppCell | moderate-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.01e-07 | 193 | 167 | 8 | 22455801194bd8c73c5c397f5eac4f723429c383 | |
| ToppCell | facs-Skin-Telogen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-07 | 194 | 167 | 8 | ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b | |
| ToppCell | facs-Skin-Telogen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-07 | 194 | 167 | 8 | bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.50e-07 | 198 | 167 | 8 | a1c8e5c332336823c47c04e56b6d7bc8f057c9da | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 8.83e-07 | 199 | 167 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.17e-07 | 200 | 167 | 8 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.47e-06 | 148 | 167 | 7 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 2.09e-06 | 156 | 167 | 7 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.38e-06 | 159 | 167 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Ciliated_cells-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 2.80e-06 | 163 | 167 | 7 | 43194c6127df1ce3d29242f719645de3c11fd7c0 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Liver / Manually curated celltypes from each tissue | 3.16e-06 | 166 | 167 | 7 | 9afa33b5ad27dc33576be592f9b22d8161366838 | |
| ToppCell | Ciliated_cells-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.70e-06 | 170 | 167 | 7 | 8b7ef1464ea589886b575ebad5447b085cbdcdba | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-06 | 182 | 167 | 7 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | facs-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-06 | 182 | 167 | 7 | 4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|World / Stress and Cell class | 6.45e-06 | 185 | 167 | 7 | b8cd94cf18308b514fc61557550225794ffd2860 | |
| ToppCell | Ciliated_cells-A|World / lung cells shred on cell class, cell subclass, sample id | 7.68e-06 | 190 | 167 | 7 | cd87731aaa7d252424f79cfce9f7931457f17bdf | |
| ToppCell | facs-Lung-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-06 | 190 | 167 | 7 | fe844559b95832845d2e8d3ab4b57e3d558bc372 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-06 | 190 | 167 | 7 | e243b5fbb17b9ec3cc90bbe970c1d30b0fd1c2e1 | |
| ToppCell | COVID-19-kidney-Stressed_EC|kidney / Disease (COVID-19 only), tissue and cell type | 7.95e-06 | 191 | 167 | 7 | d35aa842b813ea0eff7362abc894cca4e86b2fb2 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 8.50e-06 | 193 | 167 | 7 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | facs-Bladder-nan-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-06 | 194 | 167 | 7 | f4c9fc53ae31d58096906d9305b0b4082512a7e9 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-06 | 194 | 167 | 7 | 4d7fc4d0a55abb3b645116d13a983bbedc55f70c | |
| ToppCell | facs-Heart-LA-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-06 | 194 | 167 | 7 | 33cc4f1d716cb71d54cdedbe9bbdc0d7b17c4777 | |
| ToppCell | moderate-Myeloid-Monocyte-derived_Macrophage|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.09e-06 | 195 | 167 | 7 | 9c9634906168239cf978adb398787692437bf9e7 | |
| ToppCell | facs-Bladder-nan-18m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.09e-06 | 195 | 167 | 7 | 3e4f9ecfaa756386d816a26313b7229ec092d4e6 | |
| ToppCell | COVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters | 9.09e-06 | 195 | 167 | 7 | bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 9.09e-06 | 195 | 167 | 7 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.40e-06 | 196 | 167 | 7 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | droplet-Bladder-BLADDER|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-06 | 197 | 167 | 7 | 5ae84f796005fa7b75d10b6464770da6cd5c8f53 | |
| ToppCell | droplet-Bladder-BLADDER-1m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-06 | 197 | 167 | 7 | 1e24150c5146c93914aaaa981bd17589e8ed7cf9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.72e-06 | 197 | 167 | 7 | 02cc9d39afefa5e5b6f5d93f9adc3a20050b70dd | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-06 | 197 | 167 | 7 | 036c4c9b3ae80e2dc21c24a84504d3da0541f945 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 199 | 167 | 7 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.04e-05 | 199 | 167 | 7 | 0d1f2b0d10c1f8ee10c448659b2a22ea0a6a6f0d | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 199 | 167 | 7 | 7ee2805fd9143eba11bf6832267b62189683608b | |
| ToppCell | 18|World / Age, Tissue, Lineage and Cell class | 1.04e-05 | 199 | 167 | 7 | ef043232ee028778b8ddb92aeed7584e2bf586d5 | |
| ToppCell | COVID-19|World / group, cell type (main and fine annotations) | 1.07e-05 | 200 | 167 | 7 | ac38a468559c33ee00152735ce6e408f3f48df84 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 200 | 167 | 7 | 2f5b71e55c2de0e77fdae6667eb57f333acc6cd1 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 200 | 167 | 7 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 200 | 167 | 7 | efdbd1273b07d9fe957380e347b5b6b45db0a271 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 200 | 167 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 200 | 167 | 7 | 9ca86928fceaa1fefd0f9ffcfa5cc0a210ee5792 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Activated_fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.07e-05 | 200 | 167 | 7 | 2518d1758e2730b028270e76b949cebbeb7fb5ce | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.26e-05 | 136 | 167 | 6 | 47663c5d81c766a333207a44fc5b58b07309ee76 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.26e-05 | 136 | 167 | 6 | 6d2e5b871f4cf8d64e6fe0be666fb3490797c635 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.26e-05 | 136 | 167 | 6 | fd4269d194c7c11c6ab4383393a01efab05cbace | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.26e-05 | 136 | 167 | 6 | 3f6cec8d52c84191f7f6e2dd4dc47524dfd5b21b | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.26e-05 | 136 | 167 | 6 | 67d736096d6b6ddb4722809557f5e987063b8d23 | |
| ToppCell | Endothelial-F|World / shred on cell class and cell subclass (v4) | 1.43e-05 | 139 | 167 | 6 | 32d3c5d35e6c4205711c3500d736fd108443e6b4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-05 | 155 | 167 | 6 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-05 | 155 | 167 | 6 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 160 | 167 | 6 | 830e3ef8c9708d25872c3052a0b2682fa9372111 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.27e-05 | 161 | 167 | 6 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-05 | 161 | 167 | 6 | a006491c991e6a134be20ad75092a91f3b7c3c91 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.39e-05 | 162 | 167 | 6 | 388670cf3acef17df971c0d8ae3ce14398945192 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.39e-05 | 162 | 167 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.39e-05 | 162 | 167 | 6 | 9333d923225df7bfdf6b3a4c32816751315aec50 | |
| ToppCell | normal_Lung-Epithelial_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass | 3.63e-05 | 164 | 167 | 6 | fa2dae15b38cb8f9642dbf00549beec8ee19e9bb | |
| ToppCell | 343B-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.88e-05 | 166 | 167 | 6 | 4e47e7f3019fb2dcbc35b4e9b47ee265a97cec5c | |
| ToppCell | 343B-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.88e-05 | 166 | 167 | 6 | f6e2ec767c022982ef416fadb998a7b6b958f76a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-05 | 167 | 167 | 6 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.15e-05 | 168 | 167 | 6 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Pulmonary_NE_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.43e-05 | 170 | 167 | 6 | 98d13dbd76a826e47d55553f9d11f71c043b573e | |
| ToppCell | Ciliated_cells-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.43e-05 | 170 | 167 | 6 | 3d3a03979014df3a05c49be18010c6b94d786707 | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.58e-05 | 171 | 167 | 6 | 3112d15f2a28cf4a71992db4971d960716dc1264 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.89e-05 | 173 | 167 | 6 | a809be2630d2b91b53b82b5e2bb99e05524597c1 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.05e-05 | 174 | 167 | 6 | 179a52d77899a929396b98d4ab2c270dd2ec708e | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.05e-05 | 174 | 167 | 6 | 9165a1094d345328e58962f4b2a20334c3e93ead | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Promonocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.21e-05 | 175 | 167 | 6 | 654299df246debe0a5b12f0d9568eb828bb94bb9 | |
| ToppCell | (03)_Secretory-(4)_1wkpi|(03)_Secretory / shred by cell type and Timepoint | 5.21e-05 | 175 | 167 | 6 | 06b52f85baa31b55bb31477244892b6da79fe2c9 | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.38e-05 | 176 | 167 | 6 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 5.38e-05 | 176 | 167 | 6 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 5.55e-05 | 177 | 167 | 6 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.55e-05 | 177 | 167 | 6 | d5640f0097878f0dac671e51dc51310278bb2682 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.55e-05 | 177 | 167 | 6 | f10f77130dbb2c0ad1b436ceb4fb1deac2b0267c | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(1)_Control_(PBS) / Stress and Cell class | 5.55e-05 | 177 | 167 | 6 | d9e5ac5b8949a77e88e8094079167e4cf2c1bbd1 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.55e-05 | 177 | 167 | 6 | d947ba38db1772fc5fdcdc211f7511c4aa699dee | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.55e-05 | 177 | 167 | 6 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 178 | 167 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 5.73e-05 | 178 | 167 | 6 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.91e-05 | 179 | 167 | 6 | 6624a2e731ab2d6c2eec19445e3dc509f581a8a9 | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.91e-05 | 179 | 167 | 6 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.09e-05 | 180 | 167 | 6 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-05 | 181 | 167 | 6 | 8fcdab61fad2efd324d2b27c58f5a594f1dc15de | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.28e-05 | 181 | 167 | 6 | b193f3606554adc55c5906219d114288bb1f978a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.28e-05 | 181 | 167 | 6 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 6.48e-05 | 182 | 167 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.48e-05 | 182 | 167 | 6 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.48e-05 | 182 | 167 | 6 | be48ce85991bceeff938ba080e6bf9cc62176b05 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Dendritic-cDC1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.68e-05 | 183 | 167 | 6 | ab38264daddccdf5ffb75ff2210b27423eca6bc0 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.68e-05 | 183 | 167 | 6 | 263bfa1d8a7314bc3156c735c403c3bab8ea4dac | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.68e-05 | 183 | 167 | 6 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | PND10-Immune-Immune_Myeloid-Dendritic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.68e-05 | 183 | 167 | 6 | e4911601dca2c0ecb448cdb6b222dedfc0c8bf6c | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 6.68e-05 | 183 | 167 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.88e-05 | 184 | 167 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.88e-05 | 184 | 167 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.88e-05 | 184 | 167 | 6 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.88e-05 | 184 | 167 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| Drug | naringenin chalcone | 1.29e-08 | 5 | 164 | 4 | ctd:C027329 | |
| Drug | anthrarobin | 1.29e-08 | 5 | 164 | 4 | ctd:C032186 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 3.85e-08 | 6 | 164 | 4 | ctd:C543211 | |
| Drug | alloin | 3.85e-08 | 6 | 164 | 4 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 3.85e-08 | 6 | 164 | 4 | ctd:C107497 | |
| Drug | 2',4'-dihydroxychalcone | 8.93e-08 | 7 | 164 | 4 | ctd:C059354 | |
| Drug | SureCN12722713 | 1.45e-07 | 18 | 164 | 5 | CID005488034 | |
| Drug | 1,4-dihydroxyanthraquinone | 1.78e-07 | 8 | 164 | 4 | ctd:C034890 | |
| Drug | AC1MRQNQ | 3.18e-07 | 9 | 164 | 4 | CID003522271 | |
| Drug | DHPASiU | 3.18e-07 | 9 | 164 | 4 | CID000197602 | |
| Drug | 3-iodophenol | 3.18e-07 | 9 | 164 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 3.18e-07 | 9 | 164 | 4 | CID000186631 | |
| Drug | Chebi:32663 | 3.18e-07 | 9 | 164 | 4 | CID005460873 | |
| Drug | 2,6-dihydroxyanthraquinone | 5.27e-07 | 10 | 164 | 4 | ctd:C034889 | |
| Drug | amidoxime | 5.53e-07 | 23 | 164 | 5 | CID000465967 | |
| Drug | 4-nitrophenyl)imidazole | 8.23e-07 | 11 | 164 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 8.23e-07 | 11 | 164 | 4 | CID006442661 | |
| Drug | N-OH-DABZ | 1.23e-06 | 12 | 164 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 1.23e-06 | 12 | 164 | 4 | CID000088735 | |
| Drug | 4-hydroxyestrone | 1.23e-06 | 12 | 164 | 4 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 1.23e-06 | 12 | 164 | 4 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 1.23e-06 | 12 | 164 | 4 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 1.23e-06 | 12 | 164 | 4 | CID000276709 | |
| Drug | hydratropic acid | 1.46e-06 | 4 | 164 | 3 | ctd:C013025 | |
| Drug | AC 110 | 1.46e-06 | 4 | 164 | 3 | CID000022860 | |
| Drug | 2-vanillin | 1.46e-06 | 4 | 164 | 3 | ctd:C060843 | |
| Drug | diphenylacetic acid | 1.46e-06 | 4 | 164 | 3 | ctd:C037760 | |
| Drug | 2-hydroxyestrone | 1.76e-06 | 13 | 164 | 4 | ctd:C024980 | |
| Drug | tritanol | 1.76e-06 | 13 | 164 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.76e-06 | 13 | 164 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 1.76e-06 | 13 | 164 | 4 | CID000000411 | |
| Drug | alizarin | 1.76e-06 | 13 | 164 | 4 | ctd:C010078 | |
| Drug | AC1L1JAL | 1.88e-06 | 29 | 164 | 5 | CID000004954 | |
| Drug | propranolol glucuronide | 2.46e-06 | 14 | 164 | 4 | CID000119515 | |
| Drug | PCB-61 | 2.46e-06 | 14 | 164 | 4 | CID000036401 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 3.33e-06 | 15 | 164 | 4 | CID000040469 | |
| Drug | afloqualone | 3.33e-06 | 15 | 164 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 3.33e-06 | 15 | 164 | 4 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 3.33e-06 | 15 | 164 | 4 | CID000010752 | |
| Drug | bergamottin | 3.33e-06 | 15 | 164 | 4 | ctd:C068337 | |
| Drug | sulforaphane nitrile | 3.33e-06 | 15 | 164 | 4 | CID000543743 | |
| Drug | isovaleric acid | 3.63e-06 | 5 | 164 | 3 | ctd:C008216 | |
| Drug | biphenylylacetic acid | 3.63e-06 | 5 | 164 | 3 | ctd:C012776 | |
| Drug | quercetin-3,4'-diglucoside | 4.41e-06 | 16 | 164 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 4.41e-06 | 16 | 164 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 4.41e-06 | 16 | 164 | 4 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 5.74e-06 | 17 | 164 | 4 | CID000003573 | |
| Drug | 6-hydroxychrysene | 5.74e-06 | 17 | 164 | 4 | CID000037766 | |
| Drug | 3,4-dihydroquinazoline | 7.22e-06 | 6 | 164 | 3 | CID000583065 | |
| Drug | formetanate | 7.22e-06 | 6 | 164 | 3 | ctd:C100163 | |
| Drug | geranylgeranylacetone | 7.22e-06 | 6 | 164 | 3 | ctd:C031049 | |
| Drug | 3-phenylpropionic acid | 7.22e-06 | 6 | 164 | 3 | ctd:C035253 | |
| Drug | Indoprofen | 7.22e-06 | 6 | 164 | 3 | ctd:D007216 | |
| Drug | alpha-sialylcholesterol | 7.22e-06 | 6 | 164 | 3 | CID000133976 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 7.34e-06 | 18 | 164 | 4 | CID000152226 | |
| Drug | Br 2 | 7.34e-06 | 18 | 164 | 4 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 7.34e-06 | 18 | 164 | 4 | CID000036614 | |
| Drug | ApApG | 7.34e-06 | 18 | 164 | 4 | CID003081975 | |
| Drug | C1 11-32 | 7.34e-06 | 18 | 164 | 4 | CID000443077 | |
| Drug | C11131 | 7.34e-06 | 18 | 164 | 4 | CID000443076 | |
| Drug | pregnenolone-16 alpha-carbonitrile | 8.84e-06 | 67 | 164 | 6 | CID000015032 | |
| Drug | 9-OH-risperidone | 9.24e-06 | 19 | 164 | 4 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 9.24e-06 | 19 | 164 | 4 | CID000091433 | |
| Drug | almokalant | 9.24e-06 | 19 | 164 | 4 | CID003033962 | |
| Drug | harmol | 9.79e-06 | 40 | 164 | 5 | CID000068094 | |
| Drug | tectochrysin | 1.15e-05 | 20 | 164 | 4 | CID005281954 | |
| Drug | AC1L1OBF | 1.15e-05 | 20 | 164 | 4 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 1.15e-05 | 20 | 164 | 4 | CID000116545 | |
| Drug | entacapone | 1.15e-05 | 20 | 164 | 4 | ctd:C071192 | |
| Drug | 5-hydroxytryptophol | 1.25e-05 | 42 | 164 | 5 | CID000009061 | |
| Drug | pirimicarb | 1.26e-05 | 7 | 164 | 3 | ctd:C011994 | |
| Drug | APMPA | 1.26e-05 | 7 | 164 | 3 | CID000512300 | |
| Drug | estriol-16-glucuronide | 1.41e-05 | 21 | 164 | 4 | CID000122281 | |
| Drug | dulcin | 1.41e-05 | 21 | 164 | 4 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 1.41e-05 | 21 | 164 | 4 | CID000069186 | |
| Drug | amonafide | 1.72e-05 | 22 | 164 | 4 | CID000050515 | |
| Drug | N-methylpiperazine | 1.72e-05 | 22 | 164 | 4 | CID000053167 | |
| Drug | plumbagin | 1.72e-05 | 22 | 164 | 4 | ctd:C014758 | |
| Drug | glabridin | 2.00e-05 | 8 | 164 | 3 | ctd:C107601 | |
| Drug | Apigenin | KDM3A UGT1A10 UGT1A8 UGT1A7 UGT1A9 HSPA1A HSPA1B HSPA5 HSPA8 | 2.00e-05 | 207 | 164 | 9 | ctd:D047310 |
| Drug | estradiol-3-glucuronide | 2.07e-05 | 23 | 164 | 4 | CID000066651 | |
| Drug | phenanthridine | 2.07e-05 | 23 | 164 | 4 | CID000009189 | |
| Drug | lamotrigine | 2.14e-05 | 116 | 164 | 7 | CID000003878 | |
| Drug | valproate | CACNA1A CACNA1B CACNA1E IMPA1 UGT1A10 UGT1A8 UGT1A7 HDAC8 UGT1A9 CPS1 SETD2 DNMT1 | 2.17e-05 | 381 | 164 | 12 | CID000003121 |
| Drug | 4-hydroxyestradiol | 2.29e-05 | 79 | 164 | 6 | CID000001743 | |
| Drug | isoamyl alcohol | 2.43e-05 | 48 | 164 | 5 | CID000031260 | |
| Drug | AS-3201 | 2.46e-05 | 24 | 164 | 4 | CID000153948 | |
| Drug | benzphetamine | 2.52e-05 | 119 | 164 | 7 | CID000002341 | |
| Drug | acridine | 2.65e-05 | 81 | 164 | 6 | CID000009215 | |
| Drug | AC1L1G0K | 2.69e-05 | 49 | 164 | 5 | CID000003473 | |
| Drug | 5-MOP | 2.92e-05 | 25 | 164 | 4 | CID000002355 | |
| Drug | Hymecromone | 2.92e-05 | 25 | 164 | 4 | ctd:D006923 | |
| Drug | AzMC | 2.92e-05 | 25 | 164 | 4 | CID000064986 | |
| Drug | N-acetylbenzidine | 2.92e-05 | 25 | 164 | 4 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 2.92e-05 | 25 | 164 | 4 | CID000006796 | |
| Drug | N-phenylmaleimide | 2.92e-05 | 25 | 164 | 4 | CID000013662 | |
| Drug | (+/-)-Abacavir | 3.28e-05 | 51 | 164 | 5 | CID000001971 | |
| Drug | Thymol | 3.43e-05 | 26 | 164 | 4 | ctd:D013943 | |
| Drug | menthol | 3.98e-05 | 87 | 164 | 6 | CID000001254 | |
| Drug | licochalcone A | 4.00e-05 | 27 | 164 | 4 | ctd:C070840 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 4.15e-09 | 5 | 160 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 4.15e-09 | 5 | 160 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 4.15e-09 | 5 | 160 | 4 | EFO_0801853 | |
| Disease | X-21339 measurement | 2.88e-08 | 7 | 160 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0800766 | |
| Disease | X-11442 measurement | 1.03e-07 | 9 | 160 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.03e-07 | 9 | 160 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.03e-07 | 9 | 160 | 4 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.03e-07 | 9 | 160 | 4 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.03e-07 | 9 | 160 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.03e-07 | 9 | 160 | 4 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.03e-07 | 9 | 160 | 4 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.03e-07 | 9 | 160 | 4 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.03e-07 | 9 | 160 | 4 | EFO_0004570, GO_0009410 | |
| Disease | indole-3-carboxylate measurement | 1.56e-07 | 3 | 160 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 1.56e-07 | 3 | 160 | 3 | EFO_0022216 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 1.56e-07 | 3 | 160 | 3 | DOID:0111181 (implicated_via_orthology) | |
| Disease | bilirubin measurement, response to tenofovir | 1.70e-07 | 10 | 160 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 1.70e-07 | 10 | 160 | 4 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 1.70e-07 | 10 | 160 | 4 | EFO_0802185 | |
| Disease | X-23974 measurement | 1.70e-07 | 10 | 160 | 4 | EFO_0800867 | |
| Disease | pregnenetriol sulfate measurement | 2.67e-07 | 11 | 160 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 2.67e-07 | 11 | 160 | 4 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 2.67e-07 | 11 | 160 | 4 | EFO_0800972 | |
| Disease | X-21796 measurement | 2.67e-07 | 11 | 160 | 4 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 2.67e-07 | 11 | 160 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 2.67e-07 | 11 | 160 | 4 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 3.98e-07 | 12 | 160 | 4 | EFO_0800079 | |
| Disease | biliverdin measurement | 3.98e-07 | 12 | 160 | 4 | EFO_0021033 | |
| Disease | pregnenetriol disulfate measurement | 5.73e-07 | 13 | 160 | 4 | EFO_0800587 | |
| Disease | retinol dehydrogenase 16 measurement | 5.73e-07 | 13 | 160 | 4 | EFO_0802007 | |
| Disease | migraine (implicated_via_orthology) | 6.23e-07 | 4 | 160 | 3 | DOID:6364 (implicated_via_orthology) | |
| Disease | serum metabolite measurement | CACNA1E CYP3A7 RGSL1 UGT1A10 UGT1A8 UGT1A7 NT5C3A UGT1A9 HUNK REV3L CPS1 BCL9 FAM151B ALMS1 SYNE2 PCDH15 HSPA8 DNMT1 CCSER1 | 9.79e-07 | 945 | 160 | 19 | EFO_0005653 |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 1.55e-06 | 5 | 160 | 3 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.88e-06 | 17 | 160 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | X-21441 measurement | 1.88e-06 | 17 | 160 | 4 | EFO_0800814 | |
| Disease | angiopoietin-related protein 1 measurement | 2.40e-06 | 18 | 160 | 4 | EFO_0801382 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 3.09e-06 | 6 | 160 | 3 | EFO_0800566 | |
| Disease | tissue factor measurement | 4.64e-06 | 21 | 160 | 4 | EFO_0010623 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 5.39e-06 | 7 | 160 | 3 | DOID:0050951 (implicated_via_orthology) | |
| Disease | vitamin D measurement, COVID-19 | 6.92e-06 | 49 | 160 | 5 | EFO_0004631, MONDO_0100096 | |
| Disease | non-high density lipoprotein cholesterol measurement | CACNA1A ZHX3 PLVAP UGT1A10 UGT1A8 UGT1A7 CARMIL1 UGT1A9 APLP2 NHLRC2 SBNO1 MACO1 SYNE2 HYDIN BRWD1 | 8.51e-06 | 713 | 160 | 15 | EFO_0005689 |
| Disease | neuroblastoma, cutaneous melanoma | 1.54e-05 | 28 | 160 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | xanthurenate measurement | 1.78e-05 | 29 | 160 | 4 | EFO_0010551 | |
| Disease | indoleacetate measurement | 1.83e-05 | 10 | 160 | 3 | EFO_0021015 | |
| Disease | response to dolutegravir | 2.04e-05 | 30 | 160 | 4 | EFO_0600017 | |
| Disease | X-24588 measurement | 4.30e-05 | 13 | 160 | 3 | EFO_0800898 | |
| Disease | vitamin D deficiency | 4.78e-05 | 37 | 160 | 4 | EFO_0003762 | |
| Disease | Bipolar Disorder | CACNA1A CACNA1B IMPA1 PCLO BCL9 ERVW-1 EGR2 DLG3 DNAH8 HSPA5 DNMT1 | 6.28e-05 | 477 | 160 | 11 | C0005586 |
| Disease | apolipoprotein B measurement | ANKRD31 UGT1A10 UGT1A8 UGT1A7 UGT1A9 NHLRC2 MACO1 SYNE2 DYNC1LI1 PLCB3 NUP93 HYDIN BRWD1 | 7.10e-05 | 663 | 160 | 13 | EFO_0004615 |
| Disease | amyloid-like protein 2 measurement | 8.73e-05 | 3 | 160 | 2 | EFO_0801380 | |
| Disease | cholelithiasis | 1.20e-04 | 88 | 160 | 5 | EFO_0004799 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.56e-04 | 147 | 160 | 6 | DOID:9352 (biomarker_via_orthology) | |
| Disease | free androgen index | 2.16e-04 | 374 | 160 | 9 | EFO_0007005 | |
| Disease | metabolite measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A9 REV3L CPS1 SHROOM2 SVOPL ALMS1 SYNE2 HERPUD2 | 2.54e-04 | 560 | 160 | 11 | EFO_0004725 |
| Disease | urate measurement, spine bone mineral density | 2.81e-04 | 58 | 160 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | L-arginine measurement, amino acid measurement | 2.89e-04 | 5 | 160 | 2 | EFO_0005134, EFO_0006524 | |
| Disease | Carcinoma, Pancreatic Ductal | 2.91e-04 | 24 | 160 | 3 | C0887833 | |
| Disease | gallstones | 3.13e-04 | 108 | 160 | 5 | EFO_0004210 | |
| Disease | Schizophrenia | CACNA1B BCL9 ERVW-1 NPRL2 SBNO1 EGR2 DLG1 DLG3 ARHGAP18 HSPA1A HSPA1B CTSK TOP3B DNMT1 | 3.40e-04 | 883 | 160 | 14 | C0036341 |
| Disease | seasonal gut microbiome measurement | 3.70e-04 | 112 | 160 | 5 | EFO_0007753 | |
| Disease | De Lange syndrome | 4.32e-04 | 6 | 160 | 2 | cv:C0270972 | |
| Disease | Cornelia de Lange syndrome (implicated_via_orthology) | 4.32e-04 | 6 | 160 | 2 | DOID:11725 (implicated_via_orthology) | |
| Disease | primary ciliary dyskinesia (is_implicated_in) | 4.32e-04 | 6 | 160 | 2 | DOID:9562 (is_implicated_in) | |
| Disease | mean platelet volume | SRRM1 RIN3 COL6A6 CARMIL1 NAB1 CPS1 PICALM ZFPM2 SETD2 SYNE2 SERPING1 DLG3 ADGRF5 ARHGAP18 MCF2L | 4.59e-04 | 1020 | 160 | 15 | EFO_0004584 |
| Disease | testosterone measurement | ZHX3 CYP3A7 POLR1A UGT1A10 UGT1A8 UGT1A7 NAB1 UGT1A9 CHORDC1 ZFPM2 EGR2 FAM186A MACO1 SYNE2 HS3ST4 SLC24A1 BRWD1 | 5.84e-04 | 1275 | 160 | 17 | EFO_0004908 |
| Disease | amino acid measurement, threonine measurement | 6.03e-04 | 7 | 160 | 2 | EFO_0005134, EFO_0009775 | |
| Disease | Cornelia De Lange Syndrome | 8.01e-04 | 8 | 160 | 2 | C0270972 | |
| Disease | benign neoplasm (implicated_via_orthology) | 8.01e-04 | 8 | 160 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | SPINOCEREBELLAR ATAXIA 17 | 1.03e-03 | 9 | 160 | 2 | C1846707 | |
| Disease | Major depression, single episode | 1.03e-03 | 9 | 160 | 2 | C0024517 | |
| Disease | thyroxine measurement | 1.10e-03 | 83 | 160 | 4 | EFO_0005130 | |
| Disease | hormone measurement | 1.15e-03 | 84 | 160 | 4 | EFO_0004730 | |
| Disease | alopecia areata (is_marker_for) | 1.28e-03 | 10 | 160 | 2 | DOID:986 (is_marker_for) | |
| Disease | senile cataract (is_implicated_in) | 1.56e-03 | 11 | 160 | 2 | DOID:9669 (is_implicated_in) | |
| Disease | peanut allergy measurement, parental genotype effect measurement | 1.56e-03 | 11 | 160 | 2 | EFO_0005939, EFO_0007017 | |
| Disease | dodecanedioate measurement | 1.86e-03 | 12 | 160 | 2 | EFO_0021054 | |
| Disease | disks large homolog 3 measurement | 1.86e-03 | 12 | 160 | 2 | EFO_0802472 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.99e-03 | 239 | 160 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | urinary bladder carcinoma | 2.13e-03 | 47 | 160 | 3 | MONDO_0004986 | |
| Disease | toxic shock syndrome (is_implicated_in) | 2.19e-03 | 13 | 160 | 2 | DOID:14115 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | KDM3A IDO1 C1orf87 UGT1A9 PPHLN1 SHROOM2 FABP4 SETD2 SBNO1 SYNE2 HEATR9 ANKRD30A HSPA1B DNMT1 | 2.21e-03 | 1074 | 160 | 14 | C0006142 |
| Disease | vitamin D measurement | 2.47e-03 | 336 | 160 | 7 | EFO_0004631 | |
| Disease | N-acetylglycine measurement | 2.55e-03 | 14 | 160 | 2 | EFO_0021002 | |
| Disease | infant head circumference | 2.93e-03 | 15 | 160 | 2 | EFO_0004577 | |
| Disease | bilirubin measurement | 2.94e-03 | 442 | 160 | 8 | EFO_0004570 | |
| Disease | sphingomyelin 14:0 measurement | 3.77e-03 | 17 | 160 | 2 | EFO_0010390 | |
| Disease | Brugada syndrome | 4.70e-03 | 19 | 160 | 2 | MONDO_0015263 | |
| Disease | Obesity | 5.31e-03 | 205 | 160 | 5 | C0028754 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TKIIEMMPEFQKSSV | 46 | Q9H0P0 | |
| QEITTKQMLPIVLKM | 526 | P30154 | |
| MTSEEVVQKMTGLKV | 81 | P43235 | |
| SLQVVLKSIMKAMIP | 211 | O00555 | |
| LKEPMTVSSDQMAKL | 211 | P07451 | |
| QPMKAERAGSIMVKE | 256 | P54793 | |
| EQPMVLEKTASLMLK | 266 | P51689 | |
| MKAMQSLVKIPEIQA | 111 | Q9Y3E7 | |
| PMTVLKENVMLQSQK | 476 | P32519 | |
| KSKVTINIQFPEMKM | 1326 | Q9BXX2 | |
| SLQIVLKSIMKAMVP | 206 | Q15878 | |
| EPTEKKMARAKTVMN | 331 | P26358 | |
| QEAAMKLETEKMTPA | 1641 | Q8N7X0 | |
| MEVQMKVKTNASQVP | 566 | P51816 | |
| MTEKPEMTAEEKQTL | 311 | Q96G28 | |
| ISIFIKPKSMENIME | 826 | Q12959 | |
| PIEAMVSKIEKMLSE | 2266 | Q7Z2Y8 | |
| SMAIRPKTITEKMLI | 11 | P28566 | |
| NKIIIPMMTVIKSDS | 2401 | Q8TCU4 | |
| IPTKALELMDMQTFK | 856 | Q9BXX3 | |
| MEMVKASATVDIVQK | 51 | Q9Y6B7 | |
| LKMKRVLQESADMSP | 636 | Q9C0I3 | |
| IPSLQVVLKSIMKAM | 206 | Q00975 | |
| MMQAEETPKTPLQKS | 276 | O75185 | |
| VSPLQKSEVVEMVKK | 776 | Q9Y2Q0 | |
| SDAMPEIMVKIIGSK | 11 | Q8N0U7 | |
| KKPSTEEAIMMPVIL | 371 | Q8WWL7 | |
| IIVPIMMLAIKEASA | 146 | O00203 | |
| IIVPIMMLAIKEAAS | 141 | Q13367 | |
| EKNATMPVTMLIRVK | 436 | Q9UKX7 | |
| MVKQMTDVLLTPATD | 226 | Q8N1F7 | |
| KVPSTLMDVNVLMAV | 966 | Q6ZS30 | |
| SVMKPENMIVPIKLS | 226 | Q7Z5L2 | |
| METALAKTPQKRQVM | 1 | Q9Y5E4 | |
| MMTAKAVDKIPVTLS | 1 | P11161 | |
| IMTIIEPVSKKMETA | 136 | A0A1B0GVH7 | |
| VSLQGKPMMSNLKEI | 261 | Q8IXQ6 | |
| PTSMALDRVAKSMKV | 341 | Q15124 | |
| AVDPEKAAQMKSQVM | 516 | Q06481 | |
| NKNKMMPVLSEDTIL | 81 | Q8N7Z5 | |
| ASENESMRKVMPITK | 896 | Q9C0D6 | |
| KAVQPLLKVSMSMRD | 501 | Q9NVI1 | |
| SAIKVIPTVFKAMQM | 176 | P14902 | |
| VMLEKKIRTSSMPEQ | 271 | Q86WA8 | |
| MTVENIPSMPKRTAK | 106 | O60721 | |
| ALSSQQPEKVMAKQM | 361 | Q13506 | |
| PVMKLVEVIKTPMTS | 176 | Q16836 | |
| DITMVPQASEILAKM | 506 | Q8WW38 | |
| LKDTLVMLVVDMSKP | 141 | Q9Y6G9 | |
| SSKDMVKMFPLLVEK | 1086 | Q5H9U9 | |
| KRAVAELDMATPKTM | 6746 | Q5CZC0 | |
| KQKIAEVMAVMPSIT | 611 | Q8N5G2 | |
| PEEISSMVLTKMKEI | 116 | P0DMV9 | |
| VKETLSMEKIPPMVT | 1176 | Q9Y6V0 | |
| SMEKIPPMVTTDQKQ | 1181 | Q9Y6V0 | |
| LDTCIKTKSQPMMPV | 386 | Q9BX97 | |
| TVPKMLLDQVMGVNK | 81 | Q6IEZ7 | |
| STIVPKMLVDQVMSQ | 66 | P0C7T2 | |
| FVNLMTPKMKKVESV | 661 | Q96JB1 | |
| KLDFKSLAVVEPSMM | 101 | Q6UXP7 | |
| LQEMTKMASRPFAKV | 2686 | Q7Z7M0 | |
| NDIMLVKMASPVSIT | 141 | Q9UBX7 | |
| IPKEFVGQIMTMLNK | 1541 | Q7Z3U7 | |
| MRPNSKTTKELDKMI | 276 | Q8NGH3 | |
| QMPQNKTTKFMEAVI | 976 | Q86VI3 | |
| AKDVVMEPTMKTLSD | 921 | Q9H0A0 | |
| IKVMDLETKMVSVLP | 556 | Q8NBF2 | |
| ITKPSIMDKVQDFME | 126 | Q6P4A8 | |
| LTNSSQIDKPMKMEK | 706 | Q9NY74 | |
| TVPKMLLDQVMGVNK | 81 | Q8NH02 | |
| VETKAMEQLTKSPME | 621 | Q01970 | |
| NLMPAEKIKSSMTQL | 1851 | Q96QU1 | |
| ITPKMLMSFVSRKNI | 76 | Q8NGG6 | |
| AMKEENVKTVLMNPN | 451 | P31327 | |
| PLMKVKSEMIDITRS | 256 | Q8N6G5 | |
| VTMKSDVPINLKNMR | 3711 | Q4G0P3 | |
| PMAVVSKQVNMELAK | 341 | O60341 | |
| QMVISEKEAMSTIEP | 631 | Q9Y4C1 | |
| AMISLEIPQVNIMTK | 161 | Q9UHW5 | |
| EDTEKFLTLMKMPVI | 441 | Q9BX69 | |
| LIKDAIVSTQPAMMV | 241 | O14523 | |
| MVSPMKPLEIKTQCS | 171 | Q86TI2 | |
| KSKQEVMVRPPTVMS | 21 | O00512 | |
| LTSAIKPEIAKMLME | 131 | O15063 | |
| KPATTKPMVKMSREV | 2981 | P12111 | |
| RTMKIIMKVGQDPNA | 156 | P98172 | |
| MKKTPVFLESLVTNM | 1 | Q53R41 | |
| KMVDKEMNPLPTQLS | 276 | P57058 | |
| EQKSRIQAMKPMTKE | 161 | Q66PJ3 | |
| IFIKPKSIEALMEMN | 741 | Q92796 | |
| KDAVQMPSETLKAKM | 2211 | Q9NSI6 | |
| MPSETLKAKMVPEKV | 2216 | Q9NSI6 | |
| PSVFKAIMEKLEMSK | 376 | P05155 | |
| AIMEKLEMSKFQPTL | 381 | P05155 | |
| MSTMKIPPQTKVEES | 276 | Q8IWC1 | |
| DDFKMKVPVIMLSSV | 186 | O15068 | |
| MKVAQRMAQKSAAVP | 746 | O75064 | |
| IMKKVSMEPSERLAS | 126 | Q5VZK9 | |
| MDQSGMEIPVTLIIK | 1 | Q9BSE4 | |
| ILVPNEELSMVMSSK | 2031 | Q8WYP5 | |
| RKVAGMAKPNMIISV | 31 | P15090 | |
| PEEISSMVLTKMKEI | 116 | P0DMV8 | |
| EIMSSKVLSPMVEKA | 3216 | Q8NDH2 | |
| EKVADMTSVLDPNKM | 5146 | Q8NDH2 | |
| MLAITDPDMIKTVLV | 81 | P24462 | |
| KELEKMVIQTPMTLS | 996 | A6NE01 | |
| HKQMRIVKPKVASME | 51 | Q9BY41 | |
| IVKPKVASMEEMATF | 56 | Q9BY41 | |
| STKKARNPEVVMVEM | 426 | A2RUR9 | |
| FASKRKVLMVEEPSM | 476 | P00395 | |
| APEEISAMVLTKMKE | 141 | P11021 | |
| NMDLFRSTMKPVQKV | 331 | P11021 | |
| LEIVMKSIVNLDSPM | 1046 | A3KN83 | |
| LVKPTVTISVDGKMM | 36 | Q0Z7S8 | |
| TFGMVVKMLIEKDPS | 311 | Q8NEY8 | |
| MSCEVLVTFKPMINK | 576 | Q9C0B2 | |
| NVMPKTLDGQITMEK | 246 | Q9Y661 | |
| VKMFITKMISSLPIE | 46 | A6NMZ7 | |
| EIKMQSMQTPLGKTR | 1521 | Q13029 | |
| VIMPEMLVVLSTEKT | 76 | Q8NH74 | |
| TSVPEVPMMEKILQK | 731 | Q8TB24 | |
| PEEVSSMVLTKMKEI | 116 | P11142 | |
| MVAEVSPKLAASPMK | 1 | Q6S8J7 | |
| VMVLMDGSVKLVTPE | 721 | Q92918 | |
| EKVVIQMPSLKMASS | 286 | A5PLK6 | |
| AVHPNKVSMMEKSEL | 146 | Q9UGT4 | |
| EAVKLQMEPKMQSKT | 481 | Q9UQF0 | |
| QVTVKLPLMKINFDM | 1526 | O95602 | |
| MEKLPSRKAITEMIS | 5056 | Q8WXH0 | |
| PIPKISESKMAFKQM | 76 | Q9UI15 | |
| VPLESVKEMLKSVMQ | 736 | P0DJD1 | |
| AIKNEMNVMLKSSPV | 26 | P29218 | |
| MNVMLKSSPVDLVTA | 31 | P29218 | |
| VDEDVKLMMSTLPKS | 591 | P10244 | |
| IVVHTKMMIDPNAKT | 586 | Q96QH2 | |
| MDNNTTVKMVPIKIV | 1201 | Q13796 | |
| PSVKIKTTMDLMEGI | 1336 | Q13796 | |
| SLLSPMSVNAVMKVI | 181 | P50991 | |
| NKILVDMAKMRPTTV | 1181 | Q14191 | |
| KPSKELAELVMFMAQ | 51 | Q9NVU7 | |
| MEESKQKLVPIMTIL | 121 | Q8WTW4 | |
| APKTQSIMMQVLDKG | 61 | Q15198 | |
| LKLVMSFPKMEETTK | 1821 | Q6Q759 | |
| AKMNRSVMPEGKLVE | 246 | Q8N434 | |
| MAKALIKSPSQDEML | 731 | Q8IZF2 | |
| PMVVMKNVLVKQGSS | 91 | Q9C0C6 | |
| TATKIEITMRKAEPM | 296 | Q9UHD1 | |
| MRTMNTEKLLKTVPI | 156 | Q13492 | |
| MKTVLMVAEKPSLAQ | 1 | O95985 | |
| VATVMPMKIQVSNTK | 1306 | A0JNW5 | |
| KIMATPEQVGKMKAI | 451 | P12956 | |
| EVHTKEQMLTMLPKE | 91 | Q7Z7L9 | |
| SMVSEIPEKKAMAIA | 306 | Q9HAW8 | |
| MKVSLKTALQPMVSA | 431 | P07911 | |
| ILMVDEKMSPTIGKQ | 536 | P42285 | |
| SNSPKMVEDKKIVIM | 1981 | O60673 | |
| PVKDRMEMPTATQKT | 56 | Q96C74 | |
| EVKNPDSKMMQINLT | 76 | Q8IYB3 | |
| NISEPTKKVMEMIPQ | 96 | O95073 | |
| AQTVEELKLKPTMMN | 391 | A2RTY3 | |
| LKMVLKKMQEAPESA | 241 | O95551 | |
| EMAPSDLLVLTKMFK | 226 | Q5SRE5 | |
| ITVLQMKEMKVSDIP | 1211 | Q5SRE5 | |
| AAPNMKAMEKLESVR | 1021 | Q14683 | |
| IKKAINMRSPVMSTL | 306 | Q96LQ0 | |
| EMPMQTLVPAKVASK | 276 | P07602 | |
| SMVSEIPEKKAMAIA | 306 | O60656 | |
| MNQESTTIKVMEKPP | 46 | Q8N392 | |
| VPLQVDSTPKMKMEI | 106 | Q9BYW2 | |
| DKNSVKTDLMKAPMV | 201 | Q6UWB4 | |
| SINVIMQPLEKMALK | 66 | Q8N7F7 | |
| LQIEKAGPVAIMKTM | 306 | Q2M3R5 | |
| TKIPTLVQIIKSQMM | 281 | Q9UI38 | |
| QAEIIITKTPIMKIM | 176 | Q9H4I2 | |
| SMVSEIPEKKAMAIA | 306 | Q9HAW7 | |
| SMVSEIPEKKAMAIA | 306 | Q9HAW9 | |
| KMETRMIKNVCAPAV | 461 | Q2WGJ6 | |
| KPVTDMKESLIMNHV | 5841 | P20929 |